Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)

SHE:000153 Revenue

Anhui Fengyuan Pharmaceutical had revenue of 835.44M CNY in the quarter ending June 30, 2026, a decrease of -23.10%. This brings the company's total for the last twelve months to 3.50B, down -12.52% year-over-year. In the year 2025, Anhui Fengyuan Pharmaceutical had annual revenue of 3.86B, down -9.95%. That makes Anhui Fengyuan Pharmaceutical the 10,952nd largest company in the world by revenue and 1,821st in China.

• Revenue (ttm): 3.50B
• Revenue Growth: -12.52%
• P/S Ratio: 0.74
• Revenue / Employee: 818.71K
• Employees: 4,278
• Market Cap: 2.60B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Drug Retail Distribution 2.22B 57.5%
• Pharmaceutical Manufacturing 1.51B 39.0%
• Unallocated Others 135.43M 3.5%

Fiscal year ended Dec 31, 2025 See the full SHE:000153 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.86B	-426.41M	-9.95%
Dec 31, 2024	4.28B	9.18M	0.21%
Dec 31, 2023	4.28B	271.42M	6.78%
Jan 1, 2023	4.00B	351.80M	9.63%
Jan 1, 2022	3.65B	331.03M	9.97%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error